col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

238 Results       Page 1

Elsevier: Thrombosis Research
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―12 COVID-19 infection and risk stratification for pulmonary embolism: Identifying optimal D-dimer thresholds Damon E. Houghton, Ana I. Casanegra, Waldemar E. Wysokinski, Leslie J. Padrnos, Ewa Wysokinska, Rajiv Pruthi, et al. (+4)
2 [GO] 2023―Dec―21 Whole blood viscoelastic testing profile and mortality in patients hospitalized with acute COVID-19 pneumonia: A systematic review and meta-analysis Luca Spiezia, Elena Campello, Paolo Simioni, Mario I. Lumbreras-Marquez
3 [GO] 2023―Sep―16 Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study Daphne J. Theodorou, Stavroula J. Theodorou, Dimitrios Rizos
4 [GO] 2023―Aug―18 Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials Stefano Barco, Saverio Virdone, Andrea Götschi, Walter Ageno, Juan I. Arcelus, Roland Bingisser, et al. (+30)
5 [GO] 2023―Jul―19 Thrombocytopenia is associated with a dysregulated host response in severe COVID-19 Brent Appelman, Erik H.A. Michels, Justin de Brabander, Hessel Peters-Sengers, Rombout B.E. van Amstel, Sophie M. Noordzij, et al. (+9)
6 [GO] 2023―Jun―28 Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence Amnuay Kleebayoon, Viroj Wiwanitkit
7 [GO] 2023―Jun―24 Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes Lucia Filippi, Gianni Turcato, Marta Milan, Sofia Barbar, Eliana Miozzo, Arian Zaboli, et al. (+5)
8 [GO] 2023―Jun―15 Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination I. Ivanko, I. Ćelap, S. Margetić, D. Marijančević, J. Josipović, P. Gaćina
9 [GO] 2023―Jun―12 The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists Chantal Visser, Arjen Yousefi, Melchior C. Nierman, Menno V. Huisman, Anouk J.W. Gulpen, C. Heleen van Ommen, Marieke J.H.A. Kruip
10 [GO] 2023―May―30 Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study Behnood Bikdeli, Candrika D. Khairani, Darsiya Krishnathasan, Antoine Bejjani, Andre Armero, Anthony Tristani, et al. (+23)
11 [GO] 2023―May―20 Alterations in the megakaryocyte transcriptome impacts platelet function in sepsis and COVID-19 infection Abigail Ajanel, Elizabeth A. Middleton
12 [GO] 2023―Mar―23 Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies Sonia Elhadad, David Redmond, Adrian Tan, Jenny Huang, Beatriz Lorenzo Rodriguez, Sabrina E. Racine-Brzostek, et al. (+3)
13 [GO] 2023―Feb―10 Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial Olivier Pantet, Christophe Combescure, Zied Ltaief, Lucia Mazzolai, Séverin Jeanneret, Sara Manzocchi-Besson, et al. (+10)
14 [GO] 2023―Feb―03 SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
15 [GO] 2023―Feb―02 SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply Massimo Franchini, Daniele Focosi
16 [GO] 2023―Jan―25 Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID-19 patients Krzysztof Wójcik, Stanisława Bazan-Socha, Natalia Celejewska-Wójcik, Karolina Górka, Sabina Lichołai, Kamil Polok, et al. (+8)
17 [GO] 2023―Jan―18 Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study Marta Brambilla, Paola Canzano, Patrizia Della Valle, Alessia Becchetti, Maria Conti, Mariangela Alberti, et al. (+10)
18 [GO] 2023―Jan―02 Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study Jean-Christophe Gris, Florence Guillotin, Taissa Pereira dos Santos, Mathias Chéa, Paul Loubet, Didier Laureillard, et al. (+10)
19 [GO] 2022―Dec―28 Thrombotic events following the BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) in Aotearoa New Zealand: A self-controlled case series study Muireann Walton, Robert Tomkies, Thomas Teunissen, Thomas Lumley, Timothy Hanlon
20 [GO] 2022―Dec―18 Association between SARS-CoV-2 infection or vaccination and acquired hemophilia A: A case report and literature update Massimo Franchini, Daniele Focosi
21 [GO] 2022―Dec―01 Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study M. Hardy, I. Michaux, P. Bulpa, B. Schonau, B. Nicolay, E. de Maistre, et al. (+3)
22 [GO] 2022―Nov―25 Effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19: A systematic review and meta-analysis Meng-Fei Dai, Wen-Xiu Xin, Sisi Kong, Hai-Ying Ding, Luo Fang
23 [GO] 2022―Nov―13 Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial Davide Voci, Andrea Götschi, Ulrike Held, Roland Bingisser, Giuseppe Colucci, Daniel Duerschmied, et al. (+18)
24 [GO] 2022―Nov―08 Platelet dysfunction and thrombus instability in flow conditions in patients with severe COVID-19 Charles Tacquard, Clarisse Mouriaux, Xavier Delabranche, Catherine Bourdon, Anita Eckly, Stéphanie Magnenat, et al. (+5)
25 [GO] 2022―Oct―26 SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients Kenan Toprak, Mustafa Kaplangoray, Ali Palice, Mustafa Begenç Taşcanov, Mehmet İnanır, Tolga Memioğlu, et al. (+3)
26 [GO] 2022―Oct―22 The homophilic CD84 receptor is upregulated on platelets in COVID-19 and sepsis Lukas J. Weiss, Maria Drayss, Kristina Mott, Margret Droste, Bastian Just, Anna M. Arold, et al. (+4)
27 [GO] 2022―Oct―11 Delayed catastrophic thrombotic events in post-acute COVID-19 Abhinav Gupta, Ashis Kumar Satapathy, Pravakar Bahinipati
28 [GO] 2022―Oct―06 Circulating immune cells with megakaryocyte signature in response to COVID-19 mRNA vaccination Taisuke Kanaji, Yosuke Morodomi, Sachiko Kanaji
29 [GO] 2022―Oct―01 Tissue factor in COVID-19-associated coagulopathy Saravanan Subramaniam, Hema Kothari, Markus Bosmann
30 [GO] 2022―Sep―17 Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19 Luca Quartuccio, Arianna Sonaglia, Letizia Casarotto, Dennis McGonagle, Carla Di Loreto, Enrico Pegolo
31 [GO] 2022―Sep―15 Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients Esther M. Speksnijder, Lisa M. Hessels, Linda Muusses, Harry R. Büller, Wim G. Boersma, Suat Simsek
32 [GO] 2022―Sep―08 Anticoagulation in COVID-19 patients - An updated systematic review and meta-analysis Stefanie Reis, Maria Popp, Selina Schießer, Maria-Inti Metzendorf, Peter Kranke, Patrick Meybohm, Stephanie Weibel
33 [GO] 2022―Aug―28 Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors Minna Voigtlaender, Carolin Edler, Moritz Gerling, Julia Schädler, Benjamin Ondruschka, Ann Sophie Schröder, et al. (+10)
34 [GO] 2022―Aug―18 Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis Xin Xu, Yao Feng, Yitong Jia, Xiao Zhang, Long Li, Xuesong Bai, Liqun Jiao
35 [GO] 2022―Aug―11 Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers Wagner Angelika, Garner-Spitzer Erika, Kundi Michael, Stockinger Hannes, Pabinger Ingrid, Eichinger-Hasenauer Sabine, et al. (+4)
36 [GO] 2022―Jul―26 The long haul COVID-19 arterial thrombosis Maria Pia Borrelli, Adelaide Buora, Paolo Frigatti
37 [GO] 2022―Jul―25 Early but reversible haemostatic changes in a-symptomatic females expressing COVID-19 antibodies J.O. Williams, J. Nash, C. Whelan, B.M. Raven, A.J. Davies, J. Evans, et al. (+3)
38 [GO] 2022―Jul―22 COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data Sung-Hee Choi, Hang Nguyen, Shifa Kanjwal, Ibrahim Ibrahim, Taha Bat, Abey Thomas, Haekyung Jeon-Slaughter
39 [GO] 2022―Jul―16 Impact of pharmacist intervention on anticoagulation management and risk for potential COVID-19 exposure during the COVID-19 pandemic Lindsey C. Lee, Phillip Farwig, Lauren Kirk, Virginia D. Mitchell, Jennifer A. Sabatino, Kelli D. Barnes
40 [GO] 2022―Jul―05 Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors Rebecca Müller, Gabi Rink, Günalp Uzun, Tamam Bakchoul, Patrick Wuchter, Harald Klüter, Peter Bugert
41 [GO] 2022―Jun―25 Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry Eiji Shibahashi, Kentaro Jujo, Shunsuke Kuroda, Shingo Matsumoto, Takahide Sano, Takeshi Kitai, et al. (+9)
42 [GO] 2022―May―26 COVID-19 associated coagulopathy and thrombosis in cancer Marcel Levi, Nick van Es
43 [GO] 2022―May―18 Fatal intracranial hemorrhage in patient with thrombocytopenia and positive HIT antibodies after vaccination with ChAdOx1 nCoV-19 - VITT without thrombosis? Marijana Grgić Medić, Gordana Tomac, Vladimira Rimac, Karin Zibar Tomšić, Ivana Kraljević, Ana Boban
44 [GO] 2022―May―02 Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases Prachi Saluja, Nitesh Gautam, Sisira Yadala, Anand N. Venkata
45 [GO] 2022―Apr―20 No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19 Angelo Porfidia, Giorgio Esposto, Chiara Manzo, Paolo Santini, Roberto Pola
46 [GO] 2022―Apr―18 Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients Marko Lucijanic, Ivana Jurin, Martina Sedinic, Ena Soric, Anica Sabljic, Ivan Krecak, et al. (+6)
47 [GO] 2022―Apr―01 Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study Yugo Yamashita, Sen Yachi, Makoto Takeyama, Yuji Nishimoto, Ichizo Tsujino, Junichi Nakamura, et al. (+17)
48 [GO] 2022―Mar―31 Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis? Mehran Ghasemzadeh, Javad Ahmadi, Ehteramolsadat Hosseini
49 [GO] 2022―Mar―24 Venous thromboembolism in patients hospitalised with COVID-19 in England Lara N. Roberts, Annakan V. Navaratnam, Roopen Arya, Tim W.R. Briggs, William K. Gray
50 [GO] 2022―Mar―18 Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex Niklas Boknäs, Cia Laine, Andreas Hillarp, Ankit S. Macwan, Kerstin M. Gustafsson, Tomas L. Lindahl, Margareta Holmström
51 [GO] 2022―Feb―23 COVID-19 and thrombosis: The role of hemodynamics Sudeep Sastry, Federica Cuomo, Jayaveera Muthusamy
52 [GO] 2022―Feb―20 Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area Davide Voci, Ugo Fedeli, Ioannis T. Farmakis, Lukas Hobohm, Karsten Keller, Luca Valerio, et al. (+5)
53 [GO] 2022―Jan―20 Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine Maria Cristina Leone, Simone Canovi, Annalisa Pilia, Annamaria Casali, Luca Depietri, Tommaso Fasano, et al. (+2)
54 [GO] 2022―Jan―15 Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status Alexey A. Martyanov, Anna E. Boldova, Maria G. Stepanyan, Olga I. An, Alexander S. Gur'ev, Darya V. Kassina, et al. (+11)
55 [GO] 2021―Dec―21 Absence of COVID-19-associated changes in plasma coagulation proteins and pulmonary thrombosis in the ferret model Iris C. Kreft, Roy R.A. Winiarczyk, Fric J. Tanis, Carmen van der Zwaan, Katharina S. Schmitz, Arie J. Hoogendijk, et al. (+8)
56 [GO] 2021―Dec―20 Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? Nathan D. Nielsen, Marian A. Rollins-Raval, Jay S. Raval, Jecko Thachil
57 [GO] 2021―Dec―13 The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study Husam Abdel-Qadir, Peter C. Austin, Andrea Pang, Jacob A. Udell, William H. Geerts, Candace D. McNaughton, et al. (+7)
58 [GO] 2021―Dec―08 Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis Aída Gil-Díaz, Almudena Gil-Hernández, Ana Isabel Lozano-Jiménez, Jorge Benítez-Peña, Alicia Conde-Martel
59 [GO] 2021―Dec―07 Detection of anti-GPIbα autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination Takayuki Nakamura, Yosuke Morodomi, Sachiko Kanaji, Takashi Okamura, Koji Nagafuji, Taisuke Kanaji
60 [GO] 2021―Dec―07 Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis Marco Zuin, Matthias M. Engelen, Stefano Barco, Alex C. Spyropoulos, Thomas Vanassche, Beverley J. Hunt, et al. (+7)
61 [GO] 2021―Dec―07 Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial Farid Rashidi, Stefano Barco, Parisa Rezaeifar, Parham Sadeghipour, Samad Ghodrati, Hooman Bakhshandeh, et al. (+10)
62 [GO] 2021―Dec―06 SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia Yumei Liu, Zonghong Shao, Huaquan Wang
63 [GO] 2021―Dec―04 Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19 L.H. Willems, M. Nagy, H. ten Cate, H.M.H. Spronk, L.A. Groh, J. Leentjens, et al. (+6)
64 [GO] 2021―Nov―16 Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? Marco Zuin, Carlo Cervellati, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
65 [GO] 2021―Nov―06 COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets Hanna H. Pitkänen, Annukka Jouppila, Tuukka Helin, Vinaya Dulipati, Juha Kotimaa, Seppo Meri, et al. (+4)
66 [GO] 2021―Oct―25 Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients Mireia Constans, Raquel Santiago, Lidia Jimenez, Cristina Motllo, Rosario Lopez, Jaume Trapé, et al. (+2)
67 [GO] 2021―Oct―18 Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study Thijs F. van Haaps, Didier Collard, Frits H.M. van Osch, Saskia Middeldorp, Michiel Coppens, Martijn D. de Kruif, et al. (+16)
68 [GO] 2021―Oct―11 Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study Carmen Rodríguez, Alberto Pérez-Nieva, Luis Máiz, María del Mar Meijón, Pilar Llamas, Manuel Monreal, et al. (+2)
69 [GO] 2021―Oct―08 Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts Delphine Douillet, Jérémie Riou, Andrea Penaloza, Thomas Moumneh, Caroline Soulie, Dominique Savary, et al. (+3)
70 [GO] 2021―Oct―07 Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19 Ahmed K. Pasha, Robert D. McBane, Rahul Chaudhary, Leslie J. Padrnos, Ewa Wysokinska, Rajiv Pruthi, et al. (+5)
71 [GO] 2021―Oct―07 Covid-19 vaccination, adverse events, and detection of antibodies Søren Risom Kristensen, Jette Nybo, Annebirthe Bo Hansen, Siw Leiknes Ernstsen
72 [GO] 2021―Sep―24 Systematic screening for pulmonary embolism using the years algorithm in patients with suspected COVID-19 in the emergency department Inge H.Y. Luu, Féline P.B. Kroon, Jacqueline Buijs, Jasenko Krdzalic, Martijn D. de Kruif, Math P.G. Leers, et al. (+4)
73 [GO] 2021―Sep―21 Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic Amélie Gabet, Clémence Grave, Philippe Tuppin, Joseph Emmerich, Valérie Olié
74 [GO] 2021―Sep―17 Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group Joel G. Ray, Theodore E. Warkentin, Alison L. Park
75 [GO] 2021―Aug―28 Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways Rinkoo Dalan, Bernhard O. Boehm
76 [GO] 2021―Aug―27 Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship? Björn Stessel, Jeroen Peeters, Liesbeth Bruckers, Marijke Nulens, Ina Callebaut, Jan Poelaert, Jasperina Dubois
77 [GO] 2021―Aug―26 Impact of blood type on thrombosis and disease severity in adult COVID-19 patients Shivani Rao, Surbhi Warrior, Shengyuan Luo, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
78 [GO] 2021―Aug―25 Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients Wolmet E. Haksteen, Bashar N. Hilderink, Romein W.G. Dujardin, Rogier R. Jansen, Caspar J. Hodiamont, Pieter R. Tuinman, et al. (+3)
79 [GO] 2021―Aug―13 Morphological and functional alterations in endothelial colony-forming cells from recovered COVID-19 patients José Antonio Alvarado-Moreno, Jorge Davila-Moreno, Victor Dominguez-Reyes, Rodrigo Arreola-Diaz, Irma Isordia-Salas, Antonieta Chavez-Gonzalez, Abraham Majluf-Cruz
80 [GO] 2021―Aug―08 Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it? L. Filippi, M. Sartori, M. Facci, M. Trentin, A. Armani, M.L. Guadagnin, P. Prandoni
81 [GO] 2021―Aug―04 Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia Ching-Tai Huang, Shao-Yun Hsu, Chien-Ho Wang, Wei-En Johnny Tseng, Chin-Yu Yang, Chip-Jin Ng, et al. (+2)
82 [GO] 2021―Jul―21 Pharmacokinetics of enoxaparin in COVID-19 critically ill patients Paul Jacques Zufferey, Annabelle Dupont, Julien Lanoiselée, Anne Bauters, Julien Poissy, Julien Goutay, et al. (+5)
83 [GO] 2021―Jul―16 Thrombotic risk in children with COVID-19 infection: A systematic review of the literature Marco Zaffanello, Giorgio Piacentini, Luana Nosetti, Stefania Ganzarolli, Massimo Franchini
84 [GO] 2021―Jul―14 Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19 Floris T.M. Bosch, Matteo Candeloro, Nicola Potere, Ettore Porreca, Marcello Di Nisio, Pieter W. Kamphuisen
85 [GO] 2021―Jul―09 Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil Kendra Lys Calixto Machado, Suzana Tanquella da Rosa, Soraya Dobner, Ivan Schneider Boettcher, Gilberto Comaru Pasqualotto, Adelina Elisabeth Lehmkuhl Lopes, et al. (+4)
86 [GO] 2021―Jul―03 Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study Brandon Metra, Ross Summer, Sandra Elaine Brooks, Gautam George, Baskaran Sundaram
87 [GO] 2021―Jul―03 Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza Daniel Lachant, Dominick Roto, Stephen Rappaport, Paritosh Prasad, Neil Lachant, R. James White
88 [GO] 2021―Jun―27 Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes José Miguel Rivera-Caravaca, Benjamin J.R. Buckley, Stephanie L. Harrison, Elnara Fazio-Eynullayeva, Paula Underhill, Francisco Marín, Gregory Y.H. Lip
89 [GO] 2021―Jun―25 Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study Elena Campello, Chiara Simion, Cristiana Bulato, Claudia M. Radu, Sabrina Gavasso, Francesca Sartorello, et al. (+5)
90 [GO] 2021―Jun―19 Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: a retrospective study Alexandre Godon, Zoé Durand, Lydiane Agier, Thomas Lecompte, François Mullier, Raphaël Marlu, et al. (+6)
91 [GO] 2021―Jun―16 When to use anticoagulation in COVID-19 Matthew Moll, Jean M. Connors
92 [GO] 2021―Jun―16 Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing Anastasios Kollias, Garyphallia Poulakou, Evangelos Dimakakos, Konstantinos G. Kyriakoulis, Konstantinos Syrigos
93 [GO] 2021―Jun―08 C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study Dario Nieri, Tommaso Neri, Greta Barbieri, Sara Moneta, Giovanna Morelli, Desirè Mingardi, et al. (+42)
94 [GO] 2021―May―29 Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19 Tara M. Stanne, Annie Pedersen, Magnus Gisslén, Christina Jern
95 [GO] 2021―May―15 Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study Walter Ageno, Erica De Candia, Licia Iacoviello, Augusto Di Castelnuovo
96 [GO] 2021―May―15 Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination Jonathan Douxfils, Julien Favresse, Jean-Michel Dogné, Thomas Lecompte, Sophie Susen, Charlotte Cordonnier, et al. (+8)
97 [GO] 2021―May―08 Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region Karmele Arribalzaga, Inés Martínez-Alfonzo, Carola Díaz-Aizpun, Isabel Gutiérrez, Mario Rodríguez, Nerea Castro, et al. (+31)
98 [GO] 2021―May―03 Therapeutic anticoagulation in COVID-19 patients Anna Cristina Bertoldi Lemos, Douglas Alexandre dos Espírito Santo, Carlos Henrique Miranda
99 [GO] 2021―May―01 In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis Nicola Mumoli, Giulia Conte, Marco Cei, Josè Vitale, Riccardo Capra, Giuseppe Rotiroti, et al. (+8)
100 [GO] 2021―Apr―21 PO-21 Incidence of venous thromboembolism events in outpatients with cancer and COVID-19. A. Gutiérrez Ortiz de la Tabla, D.S. Juliao Caamaño, C. López Jiménez, C. Blanco Abad, J.L. Catoya Villa, L. Ortega Morán, et al. (+2)
101 [GO] 2021―Apr―21 PO-35 Analysis of coagulation parameters in patients with COVID-19, data from Regional Center Shtip M. Shorova
102 [GO] 2021―Apr―21 OC-01 Venous thromboembolic events during the first and second waves of Covid-19 in breast cancer patients treated in an outpatient day hospital J. Illarramendi, J.L. Modesto, E. Salgado, S. De la Cruz, J.J. Illarramendi
103 [GO] 2021―Apr―21 PO-57 Characteristics of venous thromboembolism following COVID-19 in Croatia B. Barišić, S. Zupančić-Šalek, D. Županić Krmek, M. Međugorac, E. Galić, J. Faletar
104 [GO] 2021―Apr―21 OC-03 Heparin treatment in COVID-19 patients is associated with reduced in-hospital mortality: findings from an observational multicenter study in Italy and a meta-analysis of 11 studies S. Costanzo, R. Parisi, G. de Gaetano, M.B. Donati, L. Iacoviello, A. Di Castelnuovo
105 [GO] 2021―Apr―21 PO-56 Relationship between clinical presentation of SARS-CoV-2 infection and risk of thromboembolic events and prognosis in cancer patients J.L. Catoya Villa, A. Gutiérrez Ortiz de la Tabla, D.S. Juliao Caamaño, C. López Jiménez, C. Blanco Abad, L. Ortega Morán, et al. (+2)
106 [GO] 2021―Apr―21 OC-02 Khorana risk score at diagnosis of SARS-CoV-2 infection as a predicting tool for venous thromboembolic disease development, and overall mortality, in cancer patients C. López Jiménez, C. Blanco Abad, J.L. Catoya Villa, A. Gutiérrez Ortiz de la Tabla, D.S. Juliao Caamaño, L. Ortega Morán, et al. (+2)
107 [GO] 2021―Apr―21 PO-58 Venous and arterial tromboembolic events among hospitalized cancer patients with SARS-COV2 infection C. Blanco Abad, J.L. Catoya Villa, A. Gutiérrez Ortiz de la Tabla, S. Juliao Caamaño, C. López Jiménez, L. Ortega Morán, et al. (+2)
108 [GO] 2021―Apr―20 COVID-19 and thrombotic microangiopathies Nishant R. Tiwari, Sanat Phatak, Vivek R. Sharma, Sanjay K. Agarwal
109 [GO] 2021―Apr―19 Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis Matthew Moll, Rebecca L. Zon, Katelyn W. Sylvester, Evan C. Chen, Auyon J. Ghosh, Eric Abston, et al. (+10)
110 [GO] 2021―Apr―19 Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients Paola S. Preti, Mariaconcetta Russo, Luca Caneva, Margherita Reduzzi, Francesca Calabretta, Carmine Spataro, et al. (+6)
111 [GO] 2021―Apr―19 Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy Ruben Rhoades, Ron Leong, Jason Kopenitz, Brandi Thoma, Lydia McDermott, Joseph Dovidio, et al. (+6)
112 [GO] 2021―Apr―09 D-dimer Driven Deep Vein Thrombosis Prophylaxis Strategy for Hospitalized Patients with COVID-19 Kristin Stawiarski, Ariane Loutoo, Leah Velardi, Stuart Zarich
113 [GO] 2021―Apr―08 Cerebral venous thrombosis and thrombocytopenia post- COVID-19 vaccination Massimo Franchini, Sophie Testa, Mario Pezzo, Claudia Glingani, Beatrice Caruso, Isabella Terenziani, et al. (+3)
114 [GO] 2021―Apr―01 Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic Daniela Husser, Sven Hohenstein, Vincent Pellissier, Sebastian König, Laura Ueberham, Gerhard Hindricks, et al. (+3)
115 [GO] 2021―Mar―24 COVID-19 in thrombosis research: An editorial perspective S. Barco, S.M. Bates, H.H. Versteeg, F.A. Klok
116 [GO] 2021―Mar―23 COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism Inge Kirchberger, Thomas M. Berghaus, Wolfgang von Scheidt, Jakob Linseisen, Christine Meisinger
117 [GO] 2021―Mar―08 Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study Suleman Aktaa, Jianhua Wu, Ramesh Nadarajah, Muhammad Rashid, Mark de Belder, John Deanfield, et al. (+2)
118 [GO] 2021―Mar―07 The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19 Rodolfo Jiménez-Soto, Mercedes Aguilar-Soto, Carlos Andrés Rodríguez-Toledo, Antonio Camiro Zúñiga, Roberta Demichelis
119 [GO] 2021―Mar―05 Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research Bernhard Lämmle, Heidi Rossmann
120 [GO] 2021―Feb―26 Three-month follow-up of Pulmonary Embolism in patients with COVID-19 Martin B. Whyte, Rosemary Barker, Philip A. Kelly, Elisa Gonzalez, Julia Czuprynska, Raj K. Patel, et al. (+6)
121 [GO] 2021―Feb―24 Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability T.W. van de Berg, A.M. Hulshof, Magdolna Nagy, Rene van Oerle, Jan-Willem Sels, Bas van Bussel, et al. (+3)
122 [GO] 2021―Feb―18 Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19 Peter L. Turecek, Rachel C. Peck, Savita Rangarajan, Christopher Reilly-Stitt, Michael A. Laffan, Rashid Kazmi, et al. (+10)
123 [GO] 2021―Feb―17 DIC in COVID-19 Xianghui Zhou, Zhipeng Cheng, Lili Luo, Ying Zhu, Wenyi Lin, Zhangyin Ming, et al. (+2)
124 [GO] 2021―Feb―17 Therapeutic anticoagulation in COVID-19 patients O. Belfaqeeh, J. Patel, R.N. Janapala, A. Pourmand
125 [GO] 2021―Feb―09 Fondaparinux and bleeding risk in COVID-19: unsolved question Vincenzo Russo, Riccardo Proietti, Corrado Lodigiani, Pierpaolo Di Micco
126 [GO] 2021―Feb―09 ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 Tiffany Pascreau, Sara Zia-Chahabi, Benjamin Zuber, Colas Tcherakian, Eric Farfour, Marc Vasse
127 [GO] 2021―Feb―02 Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study L.I. van der Wal, L.J.M. Kroft, L.F. van Dam, C.M. Cobbaert, J. Eikenboom, M.V. Huisman, et al. (+3)
128 [GO] 2021―Jan―26 Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: a multicenter case-control study Jasper M. Smit, Jorge E. Lopez Matta, Roel Vink, Marcella C.A. Müller, Kee F. Choi, Frank E.H.P. van Baarle, et al. (+7)
129 [GO] 2021―Jan―18 Mechanisms of thrombosis and cardiovascular complications in COVID-19 Eden M. Page, Robert A.S. Ariëns
130 [GO] 2021―Jan―07 Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study Caroline Sindet-Pedersen, Jonas Bjerring Olesen, Paul Blanche, Thomas Alexander Gerds, Jarl Emanuel Strange, Jawad Haider Butt, et al. (+8)
131 [GO] 2021―Jan―07 Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: a retrospective study Nuria Muñoz-Rivas, Ane Abad-Motos, Beatriz Mestre-Gómez, Fernando Sierra-Hidalgo, Cristina Cortina-Camarero, Rosa María Lorente-Ramos, et al. (+15)
132 [GO] 2020―Dec―30 Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave F.H.J. Kaptein, M.A.M. Stals, M. Grootenboers, S.J.E. Braken, J.L.I. Burggraaf, B.C.T. van Bussel, et al. (+19)
133 [GO] 2020―Dec―29 The effect of race on composite thrombotic events in patients with COVID-19 Charles Esenwa, Santiago R. Unda, David J. Altschul, Nikunj K. Patel, Avinash Malaviya, Johanna Seiden, et al. (+3)
134 [GO] 2020―Dec―29 Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit? Anastasios Kollias, Konstantinos G. Kyriakoulis, Nikolaos K. Syrigos, George S. Stergiou
135 [GO] 2020―Dec―26 Utility of D-Dimer in Predicting Venous Thromboembolism in Non-Mechanically Ventilated COVID-19 Survivors Peter C. Nauka, Sarah W. Baron, Andrei Assa, Laurel Mohrmann, Shawn Jindal, Erick Oran, et al. (+3)
136 [GO] 2020―Dec―11 Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: prospective results from a multi-center study Farid Rashidi, Stefano Barco, Farin Kamangar, Gustavo A. Heresi, Ashkan Emadi, Cihangir Kaymaz, et al. (+29)
137 [GO] 2020―Dec―02 Association of Anticoagulation Use with SARS-CoV2 Detection Juraj Kavecansky, Jennifer R. Dusendang, Jahan Tavakoli, Julie Schmittdiel, Gwendolyn Ho, Jodi Loyles, Ashok Pai
138 [GO] 2020―Nov―28 Discordance In Activated Partial Thromboplastin Time and Anti-factor Xa Levels in COVID-19 Patients on Heparin Therapy Matthew Lawlor, Aakriti Gupta, Lauren S. Ranard, Mahesh V. Madhavan, Jianhua Li, Andrew Eisenberger, et al. (+3)
139 [GO] 2020―Nov―27 Corrigendum to “The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management” [Thromb. Res., 194, October 2020, Pages 101-115] Mouhamed Yazan Abou-Ismail, Akiva Diamond, Sargam Kapoor, Yasmin Arafah, Lalitha Nayak
140 [GO] 2020―Nov―23 Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era Wei Qin, Fen Dong, Zhu Zhang, Bingzhu Hu, Shi Chen, Ziyang Zhu, et al. (+11)
141 [GO] 2020―Nov―17 Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome Fernando Scudiero, Angelo Silverio, Marco Di Maio, Vincenzo Russo, Rodolfo Citro, Davide Personeni, et al. (+8)
142 [GO] 2020―Nov―11 In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis Amit K.J. Mandal, Jason Kho, Adam Ioannou, Koenraad Van den Abbeele, Constantinos G. Missouris
143 [GO] 2020―Nov―07 Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study Benjamin Planquette, Alice Le Berre, Lina Khider, Alexandra Yannoutsos, Nicolas Gendron, Marie de Torcy, et al. (+18)
144 [GO] 2020―Nov―07 Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic Rachna Patel, Julia Czuprynska, Lara N. Roberts, Bipin Vadher, Catherine Rea, Raj Patel, et al. (+8)
145 [GO] 2020―Nov―06 Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units Roberta Pancani, Liliana Villari, Valentina Foci, Giulia Parri, Francesco Barsotti, Filippo Patrucco, et al. (+4)
146 [GO] 2020―Nov―06 Major cardiovascular events in patients with Coronavirus Disease 2019: experience of a cardiovascular Department of Northern Italy Raffaello Bellosta, Matteo Alberto Pegorer, Luca Bettari, Luca Luzzani, Luca Attisani, Alessandro Fossati, et al. (+6)
147 [GO] 2020―Nov―05 The effect of anticoagulation on clinical outcomes in Novel Coronavirus (COVID-19) Pneumonia in a U.S. Cohort Lei Lynn, Juan A. Reyes, Katrina Hawkins, Arjun Panda, Laura Linville, Walaa Aldhahri, et al. (+4)
148 [GO] 2020―Oct―24 Prothrombotic Disturbances of Hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Study Michaël Hardy, Isabelle Michaux, Sarah Lessire, Jonathan Douxfils, Jean-Michel Dogné, Marion Bareille, et al. (+9)
149 [GO] 2020―Oct―23 In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist Lan Wang, Fei Chen, Lang Bai, Qun Yi, Yong Peng
150 [GO] 2020―Oct―15 The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison Renée R.A.G. Brüggemann, Bart Spaetgens, Hester A. Gietema, Steffie H.A. Brouns, Patricia M. Stassen, Fabienne J. Magdelijns, et al. (+9)
151 [GO] 2020―Oct―15 COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose Thromboprophylaxis strategy Molly M. Daughety, Andrew Morgan, Erin Frost, Chester Kao, Joyce Hwang, Rachel Tobin, et al. (+4)
152 [GO] 2020―Oct―15 Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID-19 infection Alex Bourguignon, Camille Beaulieu, Wiam Belkaid, Antoine Desilets, Normand Blais
153 [GO] 2020―Oct―12 D-dimer measurement in COVID-19: Silver bullet or clinical distraction? Giuseppe Lippi, Emmanuel J. Favaloro
154 [GO] 2020―Oct―09 More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism L.F. van Dam, L.J.M Kroft, L.I. van der Wal, S.C. Cannegieter, J. Eikenboom, E. de Jonge, et al. (+2)
155 [GO] 2020―Oct―08 Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units Andrew J. Doyle, Will Thomas, Andrew Retter, Martin Besser, Stephen MacDonald, Karen A. Breen, et al. (+2)
156 [GO] 2020―Oct―08 Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence Behnood Bikdeli
157 [GO] 2020―Oct―08 Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection Mattia Trunfio, Elena Salvador, Daniela Cabodi, Letizia Marinaro, Chiara Alcantarini, Alberto Gaviraghi, et al. (+7)
158 [GO] 2020―Sep―24 Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi, Babak Sharif-Kashani, Mohsen Farrokhpour, Hooman Bakhshandeh, et al. (+32)
159 [GO] 2020―Sep―23 Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia Andrew Hsu, Yuchen Liu, Adam S. Zayac, Adam J. Olszewski, John L. Reagan
160 [GO] 2020―Sep―21 Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID) Anna Cristina Bertoldi Lemos, Douglas Alexandre do Espírito Santo, Maísa Cabetti Salvetti, Renato Noffs Gilio, Lucas Barbosa Agra, Antonio Pazin-Filho, Carlos Henrique Miranda
161 [GO] 2020―Sep―17 D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19 Justin J. Choi, Graham T. Wehmeyer, Han A. Li, Mark N. Alshak, Musarrat Nahid, Mangala Rajan, et al. (+13)
162 [GO] 2020―Sep―17 The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparin Paolo Prandoni, Anna Maria Cattelan, Laura Carrozzi, Lucia Leone, Lucia Filippi, Egidio De Gaudenzi, et al. (+2)
163 [GO] 2020―Sep―16 COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic Anna L. Parks, Andrew D. Auerbach, Jeffrey L. Schnipper, James E. Anstey, David G. Sterken, Todd E.H. Hecht, et al. (+22)
164 [GO] 2020―Sep―15 Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients Romein W.G. Dujardin, Bashar N. Hilderink, Wolmet E. Haksteen, S. Middeldorp, Alexander P.J. Vlaar, J. Thachil, et al. (+2)
165 [GO] 2020―Sep―13 Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation Domenico Paparella, Mario Colucci, Enrico Squiccimarro, Pasquale Raimondo, Federica De Palma, Prudenza Ranieri, et al. (+2)
166 [GO] 2020―Sep―13 Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Caterina Stera, Tommaso Meconi, Francesca Covani Frigieri
167 [GO] 2020―Sep―10 Association between Covid-19 and Pulmonary Embolism (AC-19-PE study) Òscar Miró, Pere Llorens, Alfons Aguirre, Laura Lozano, Sebastien Beaune, Mélanie Roussel, et al. (+3)
168 [GO] 2020―Sep―07 Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease Jan A. Ruzicka
169 [GO] 2020―Sep―03 Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency Roberto Pizzi, Giancarlo Gini, Lucia Caiano, Beniamino Castelli, Noga Dotan, Federica Magni, et al. (+4)
170 [GO] 2020―Sep―01 Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization Rajkumar Rajendram, Ghulam Abbas Kharal, Naveed Mahmood, Mubashar Kharal
171 [GO] 2020―Sep―01 Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients Nadine van Veenendaal, Thomas W.L. Scheeren, Karina Meijer, Peter H.J. van der Voort
172 [GO] 2020―Sep―01 Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity Adriana Torres-Machorro, Victor Manuel Anguiano-Álvarez, Flavio Adrian Grimaldo-Gómez, Hugo Rodríguez-Zanella, Evelyn Cortina de la Rosa, Sergio Mora-Canela, et al. (+6)
173 [GO] 2020―Aug―27 COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Serena Del Turco, Annamaria Vianello, Rosetta Ragusa, Chiara Caselli, Giuseppina Basta
174 [GO] 2020―Aug―25 Role of upfront CT pulmonary angiography at admission in COVID-19 patients Carole Jalaber, Marie-Pierre Revel, Guillaume Chassagnon, Emma Bajeux, Thibaut Lapotre, Pierre Croisille, Mathieu Lederlin
175 [GO] 2020―Aug―24 Anticoagulation and bleeding risk in patients with COVID-19 Nancy Musoke, Kevin Bryan Lo, Jeri Albano, Eric Peterson, Ruchika Bhargav, Fahad Gul, et al. (+7)
176 [GO] 2020―Aug―22 Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia L.F.M. Beenen, L.D. Bos, M.J. Scheerder, N.H.J. Lobé, M.C.A. Muller, M.J. Schultz, et al. (+5)
177 [GO] 2020―Aug―21 Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19 Maxime G. Zermatten, Olivier Pantet, Francisco Gomez, Antoine Schneider, Marie Méan, Lucia Mazzolai, et al. (+4)
178 [GO] 2020―Aug―21 Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients D.J. Hoechter, A. Becker-Pennrich, J. Langrehr, M. Bruegel, B. Zwissler, S. Schaefer, et al. (+3)
179 [GO] 2020―Aug―20 Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19 Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, et al. (+13)
180 [GO] 2020―Aug―19 Managing suspected venous thromboembolism when a pandemic limits diagnostic testing Jordan K. Schaefer, Peter K. Henke, Geoffrey D. Barnes
181 [GO] 2020―Aug―12 Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis Angelo Porfidia, Emanuele Valeriani, Roberto Pola, Ettore Porreca, Anne W.S. Rutjes, Marcello Di Nisio
182 [GO] 2020―Aug―11 Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis Setor K. Kunutsor, Jari A. Laukkanen
183 [GO] 2020―Aug―10 COVID-19 versus HIT hypercoagulability Theodore E. Warkentin, Scott Kaatz
184 [GO] 2020―Aug―09 Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care W. Thomas, D. White, S. Cox-Morton, S. MacDonald, M. Besser
185 [GO] 2020―Aug―06 Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg Francesca Pizzolo, Anna Maria Rigoni, Sergio De Marchi, Simonetta Friso, Elisa Tinazzi, Giulia Sartori, et al. (+11)
186 [GO] 2020―Aug―04 Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19 Ching-Tai Huang, Shao-Yun Hsu, Ko-Wei Chang, Chung-Guei Huang, Cheng-Ta Yang, Ming-Huei Cheng
187 [GO] 2020―Aug―04 Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients Vasiliki Tsolaki, George E. Zakynthinos, Konstantinos Mantzarlis
188 [GO] 2020―Aug―03 The reversed halo sign: Considerations in the context of the COVID-19 pandemic Edson Marchiori, Luiz Felipe Nobre, Bruno Hochhegger, Gláucia Zanetti
189 [GO] 2020―Jul―31 Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark Peter Vibe Rasmussen, Paul Blanche, Jarl Emanuel Strange, Jawad Haider Butt, Frederik Dalgaard, Kristian Kragholm, et al. (+3)
190 [GO] 2020―Jul―27 D-dimer level is associated with the severity of COVID-19 Hai-Han Yu, Chuan Qin, Man Chen, Wei Wang, Dai-Shi Tian
191 [GO] 2020―Jul―22 Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study Björn Stessel, Charlotte Vanvuchelen, Liesbeth Bruckers, Laurien Geebelen, Ina Callebaut, Jeroen Vandenbrande, et al. (+8)
192 [GO] 2020―Jul―17 Venous thromboembolism in non-critically ill patients with COVID-19 infection Antonin Trimaille, Anaïs Curtiaud, Benjamin Marchandot, Kensuke Matsushita, Chisato Sato, Ian Leonard-Lorant, et al. (+12)
193 [GO] 2020―Jul―10 Pulmonary embolism in hospitalised patients with COVID-19 Martin B. Whyte, Philip A. Kelly, Elisa Gonzalez, Roopen Arya, Lara N. Roberts
194 [GO] 2020―Jul―09 Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study Ying-yi Luan, Yan Liu, Xue-yan Liu, Bao-jun Yu, Rong-ling Chen, Mian Peng, et al. (+7)
195 [GO] 2020―Jul―09 Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019 Stephanie Hightower, Harvey Ellis, Jacob Collen, John Ellis, Ian Grasso, Joseph Roswarski, et al. (+7)
196 [GO] 2020―Jul―08 Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? Virginie Siguret, Sebastian Voicu, Marie Neuwirth, Maxime Delrue, Etienne Gayat, Alain Stépanian, Bruno Mégarbane
197 [GO] 2020―Jul―05 Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case Fehmi Hindilerden, Ipek Yonal-Hindilerden, Emre Akar, Kadriye Kart-Yasar
198 [GO] 2020―Jun―27 Demystifying pulmonary vascular complications in severe coronavirus disease-19 pneumonia (COVID-19) in the light of clinico-radiologic-pathologic correlation Arshed Hussain Parry, Abdul Haseeb Wani, Mudasira Yaseen, Mohd Iqbal Dar
199 [GO] 2020―Jun―27 The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome? Giulia Previtali, Michela Seghezzi, Valentina Moioli, Aurelio Sonzogni, Lorenzo Cerutti, Roberto Marozzi, et al. (+4)
200 [GO] 2020―Jun―26 Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship Vittorio Pavoni, Lara Gianesello
201 [GO] 2020―Jun―20 The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management Mouhamed Yazan Abou-Ismail, Akiva Diamond, Sargam Kapoor, Yasmin Arafah, Lalitha Nayak
202 [GO] 2020―Jun―19 Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases Siri Overstad, Eirik Tjonnfjord, Lamya Garabet, Synne Fronas, Jonas Bergan, Saad Aballi, Waleed Ghanima
203 [GO] 2020―Jun―18 Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review Alexander Fletcher-Sandersjöö, Bo-Michael Bellander
204 [GO] 2020―Jun―18 A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients E.H. Adam, K. Zacharowski, W. Miesbach
205 [GO] 2020―Jun―13 Portal vein thrombosis in a patient with COVID-19 A. Franco-Moreno, E. Piniella-Ruiz, J. Montoya-Adarraga, C. Ballano-Franco, F. Alvarez-Miguel, C. Peinado-Martinez, et al. (+4)
206 [GO] 2020―Jun―09 Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient Marta Guillan, Javier Villacieros-Alvarez, Sara Bellido, Concepcion Perez-Jorge Peremarch, Victor M. Suarez-Vega, Maria Aragones-Garcia, et al. (+2)
207 [GO] 2020―Jun―08 COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism? Maurizio Gabrielli, Priscilla Lamendola, Alessandra Esperide, Federico Valletta, Francesco Franceschi
208 [GO] 2020―Jun―06 Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? L.F. van Dam, L.J.M. Kroft, L.I. van der Wal, S.C. Cannegieter, J. Eikenboom, E. de Jonge, et al. (+2)
209 [GO] 2020―Jun―05 Mechanisms involved in the development of thrombocytopenia in patients with COVID-19 Yujiao Zhang, Yingying Jiao, Zongpeng Li, Mo Yang, Jieyu Ye
210 [GO] 2020―May―30 A case of COVID-19 pneumonia with cerebral hemorrhage Jingwen Li, Xi Long, Chunli Zhu, Shaoping Hu, Zhicheng Lin, Jinghong Li, Nian Xiong
211 [GO] 2020―May―29 Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom Michael J.R. Desborough, Andrew J. Doyle, Alexandra Griffiths, Andrew Retter, Karen A. Breen, Beverley J. Hunt
212 [GO] 2020―May―27 Thrombosis risk associated with COVID-19 infection. A scoping review Fatimah Al-Ani, Samer Chehade, Alejandro Lazo-Langner
213 [GO] 2020―May―23 COVID-19 and hypercoagulability in the outpatient setting Roger Emert, Payal Shah, John G. Zampella
214 [GO] 2020―May―23 ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients R. Escher, N. Breakey, B. Lämmle
215 [GO] 2020―May―16 Pulmonary embolism in coronavirus disease-19 (COVID-19) and use of compression ultrasonography in its optimal management Arshed Hussain Parry, Abdul Haseeb Wani
216 [GO] 2020―May―16 The delights and perils of publishing, knowledge-sharing and critique during a pandemic: Observations from COVID-19 coagulopathies Sajida Kazi, A. Kinga Malinowski, Maha Othman
217 [GO] 2020―May―16 Severe arterial thrombosis associated with Covid-19 infection Mahine Kashi, Aurélien Jacquin, Bassel Dakhil, Rym Zaimi, Emmanuel Mahé, Emilie Tella, Patrick Bagan
218 [GO] 2020―May―16 A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic V. Speed, R.K. Patel, R. Byrne, L.N. Roberts, R. Arya
219 [GO] 2020―May―15 Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism F. Galeano-Valle, C.M. Oblitas, M.M. Ferreiro-Mazón, J. Alonso-Muñoz, J. del Toro-Cervera, P. Demelo-Rodríguez
220 [GO] 2020―May―14 Deep venous thrombosis in a non-critically ill patient with novel COVID-19 infection Peter C. Nauka, Erick Oran, Sweta Chekuri
221 [GO] 2020―May―13 Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels P. Demelo-Rodríguez, E. Cervilla-Muñoz, L. Ordieres-Ortega, A. Parra-Virto, M. Toledano-Macías, N. Toledo-Samaniego, et al. (+7)
222 [GO] 2020―May―08 Catheter-directed thrombolysis in COVID-19 pneumonia with acute PE: Thinking beyond the guidelines S.D. Qanadli, L. Gudmundsson, D.C. Rotzinger
223 [GO] 2020―May―06 Early thromboembolic events in hospitalized COVID-19 patients Raphael J. Rosen
224 [GO] 2020―May―06 The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China Jianhong Fu, Jindan Kong, Wei Wang, Meiying Wu, Lin Yao, Zhaoyue Wang, et al. (+3)
225 [GO] 2020―May―05 Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19 infection Claudio Vitali, Antonina Minniti, Nicoletta Del Papa
226 [GO] 2020―May―05 Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid U. Zachariah, S.C. Nair, A. Goel, K.A. Balasubramanian, I. Mackie, E. Elias, C.E. Eapen
227 [GO] 2020―May―01 COVID-19 associated pulmonary thrombosis C. van Nieuwkoop
228 [GO] 2020―May―01 Arterial and venous thromboembolic disease in a patient with COVID-19: A case report Renée Brüggemann, Hester Gietema, Borefore Jallah, Hugo ten Cate, Coen Stehouwer, Bart Spaetgens
229 [GO] 2020―Apr―30 Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, M.S. Arbous, D. Gommers, K.M. Kant, et al. (+5)
230 [GO] 2020―Apr―27 The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research? Chiara Mozzini, Domenico Girelli
231 [GO] 2020―Apr―25 Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom W. Thomas, J. Varley, A. Johnston, E. Symington, M. Robinson, K. Sheares, et al. (+2)
232 [GO] 2020―Apr―23 Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy Corrado Lodigiani, Giacomo Iapichino, Luca Carenzo, Maurizio Cecconi, Paola Ferrazzi, Tim Sebastian, et al. (+6)
233 [GO] 2020―Apr―21 Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients Loris Roncon, Marco Zuin, Pietro Zonzin
234 [GO] 2020―Apr―20 Pulmonary embolism in a young pregnant woman with Covid-19 Ida Martinelli, Enrico Ferrazzi, Alessandro Ciavarella, Roberta Erra, Enrico Iurlaro, Manuela Ossola, et al. (+4)
235 [GO] 2020―Apr―20 Where do we stand with antithrombotic prophylaxis in patients with COVID-19? Alessandro Ciavarella, Flora Peyvandi, Ida Martinelli
236 [GO] 2020―Apr―15 Severe COVID-19 infection associated with endothelial activation Robert Escher, Neal Breakey, Bernhard Lämmle
237 [GO] 2020―Apr―11 Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography D.C. Rotzinger, C. Beigelman-Aubry, C. von Garnier, S.D. Qanadli
238 [GO] 2020―Apr―10 Incidence of thrombotic complications in critically ill ICU patients with COVID-19 F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, M.S. Arbous, D.A.M.P.J. Gommers, K.M. Kant, et al. (+5)

238 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.020 sec